Loading stock data…
LH
$271.16+9.15 (+3.49%)
Labcorp Holdings Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Labcorp Holdings Inc. in the Healthcare sector is trading at $271.16 with a market capitalization of $21.2B. Wall Street consensus targets $310.12 (17 analysts), implying a +14.4% move over the next 12 months. The stock is currently 8% below its 52-week high of $293.72, remaining 1.7% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +14.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$271.16
Potential Upside
8.1%
Whystock Fair Value$293.21
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus17 analysts
Buy
Mean target$310.12+14.4%
Range$270.00 – $340.00
Fundamentals
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.23B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.93
Beta
Defensive asset. Lower volatility than the S&P 500.
0.88
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.80%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.79%
Volume
Today's trading volume
397,543
Recent News
Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers
Labcorp Holdings stock snapshot Labcorp Holdings (LH) stock has been moving without a clear single catalyst, which leads many investors to focus on its fundamentals, including recent returns, revenue, earnings and its current valuation profile. See our latest analysis for Labcorp Holdings. At a share price of $256.87, Labcorp Holdings has seen its short term share price momentum cool, with the share price down over the past week and three months, while longer term total shareholder returns...
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.
3 Cash-Producing Stocks That Concern Us
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
LH or MEDP: Which Is the Better Value Stock Right Now?
LH vs. MEDP: Which Stock Is the Better Value Option?